Effects of perinatal exposure to methyl mercury on functional brain development and neurochemistry.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects* / Q000196:embryology / Q000254:growth & development / Q000378:metabolism / Q000503:physiopathology; D002802:Cholinesterases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005123:Eye / Q000254:growth & development; D005260:Female; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D006130:Growth Disorders / Q000139:chemically induced*; D007210:Indoleacetic Acids / Q000378:metabolism; D008297:Male; D008431:Maternal-Fetal Exchange; D008688:Methacholine Compounds / Q000378:metabolism; D008767:Methylmercury Compounds / Q000633:toxicity*; D009024:Morphogenesis / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size; D009949:Orientation / Q000187:drug effects; D011247:Pregnancy; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D014886:Weaning
D007210:Indoleacetic Acids; D008688:Methacholine Compounds; D008767:Methylmercury Compounds; D012701:Serotonin; D002802:Cholinesterases; D000109:Acetylcholine; D009638:Norepinephrine